What You Should Know:
- Owkin, an AI-powered biotech company, today announced the dosing of the first patient in its Phase I clinical trial of OKN4395, a novel cancer therapy designed to restore immune function in patients with advanced solid tumors.
- OKN4395 represents a novel approach to cancer treatment by targeting multiple immunosuppressive pathways simultaneously.
OKN4395 Background
OKN4395 is a first-in-class asset that selectively inhibits three
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
ActiGraph and Hyfe Launch AI-Powered Cough Detection for Clinical Trials
What You Should Know:
- ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.
- This new combined solution allows researchers to leverage Hyfe’s validated cough detection algorithms alongside ActiGraph’s industry-leading digital measures for
Read More
Inato Launches AI-Powered Patient Pre-Screening to Reduce Site Burden and Accelerate Enrollment
What You Should Know:
- Inato, the leading platform for clinical trial access and inclusivity, today unveiled new capabilities to help research sites efficiently pre-screen patients for trial opportunities.
- The company’s latest advancement integrates a series of artificial intelligence (AI) models into a unified agent that quickly and securely reviews patient records and assesses eligibility, transforming a
Read More
Lindus Health Raises $55M to Accelerate AI-Driven Clinical Trials
What You Should Know:
- Lindus Health, a company transforming the clinical trial landscape with its tech-first approach raises $55M in Series B funding round led by Balderton Capital, with participation from Visionaries Club and existing investors Creandum, Firstminute, and Seedcamp.
- The funding will fuel the continued development of Lindus Health's AI technology and eClinical platform, Citrus™, and support the company's mission to make clinical trials faster, more reliable,
Read More
Increasing Participation in Muscular Dystrophy Clinical Trials
Muscular Dystrophy (MD) refers to a group of rare genetic conditions that cause progressive muscle weakness and degeneration in patients. Some forms of MD, such as Duchenne Muscular Dystrophy (DMD), can be life threatening to heart and respiratory functions.
But recent research found that among 3,661 U.S. patients with Muscular Dystrophy, only 33% of those with Duchenne and 12% of those with Becker Muscular Dystrophy - a similar but milder and later-onset MD condition - have previously
Read More
How Digital Twins Open The Door for Next-Gen Clinical Trials
Clinical trials have been the cornerstone of medical innovation for centuries, but as the effort continues to improve patient care and speed the development of new treatments and medicines, sticking with the same old trial processes is no longer an option.
Innovative technologies like digital twins and generative AI are transforming the healthcare landscape and expanding what’s possible for the future of medicine with next-gen clinical trials.
Beyond benefits associated with
Read More
H1 and CTI Partner for Clinical Trial Optimization
What You Should Know:
- H1, on a mission to connect the world to the right doctors, today announced a strategic partnership with CTI Clinical Trial & Consulting Services (CTI), a leading global full-spectrum research service provider.
- Through this partnership, CTI will leverage H1’s Trial Landscape platform to drive data-informed clinical trial planning and execution to enhance strategic feasibility, real-world evidence, and clinical trial execution on a global scale. This
Read More
Carta Healthcare Acquires Realyze Intelligence to Enhance AI-Powered Clinical Trial Matching
What You Should Know:
- Carta Healthcare®, which ignites healthcare improvement by unlocking the power of clinical data, expanded the strength and capabilities of its AI-powered platform with the acquisition of Realyze Intelligence.
- The Realyze Intelligence solution leverages AI to match patients to clinical trials to accelerate research and reduce costs while providing patients with the latest advances in care.
Carta Healthcare and Realyze Intelligence:
Read More
Optimizing Clinical Trials with AI and Data-Driven Insights
While most technology- and innovation-oriented industries have followed the general principles of Moore’s Law, which holds that computing power would double yearly, while costs were cut in half, the life sciences industry appears to be spending more money developing fewer drugs.
According to the latest data, the cost to take a drug candidate from the discovery stage, all the way to market launch, hit $2.3 billion in 2022—a $298 million rise from 2021. Meanwhile, there were
Read More
Q/A: Medidata VP Talks Overcoming Financial Barriers to Diversity in Clinical Trials
Achieving diversity in clinical trials is crucial for developing effective and safe treatments for all populations. Yet, financial barriers often exclude underrepresented groups from participating, hindering progress towards health equity. This disparity raises critical questions about the accessibility and inclusivity of medical research.
In this insightful Q&A, Meghan Harrington, VP of Clinical Trial Financial Management at Medidata, a Dassault Systèmes brand, sheds light on the
Read More
